December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

139.82 +2.02 (+1.47%)
Streaming Delayed Price Updated: 2:43 PM EDT, Sep 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
26 27 Next >
News headline image
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today? ↗
Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook. 
Via Benzinga
News headline image
Insulet Reports Preliminary Second Quarter 2024 Revenue Results
From Insulet Corporation
Via Business Wire
News headline image
A Closer Look at 7 Analyst Recommendations For Insulet ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $26,000 Today ↗
 
Via Benzinga
News headline image
Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout. ↗
Why INSULET CORP (NASDAQ:PODD) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
News headline image
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
(PODD) - Analyzing Insulet's Short Interest ↗
 
Via Benzinga
News headline image
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation. ↗
INSULET CORP (NASDAQ:PODD), a strong growth stock, setting up for a breakout. 
Via Chartmill
News headline image
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
From Insulet Corporation
Via Business Wire
News headline image
Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
From Insulet Corporation
Via Business Wire
News headline image
$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
From Insulet Corporation
Via Business Wire
News headline image
Looking Into Insulet's Recent Short Interest ↗
 
Via Benzinga
News headline image
Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
From Insulet Corporation
Via Business Wire
News headline image
The 3 Best Diabetes Stocks to Buy in June 2024 ↗
There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy. 
Via InvestorPlace
News headline image
7 Stocks That Could Safely 10X by 2030 ↗
Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align. 
Via InvestorPlace
News headline image
Where Insulet Stands With Analysts ↗
 
Via Benzinga
News headline image
NASDAQ:PODD, a strong growth stock, setting up for a breakout. ↗
INSULET CORP (NASDAQ:PODD), a strong growth stock, setting up for a breakout. 
Via Chartmill
News headline image
Is NASDAQ:PODD suited for growth investing? ↗
INSULET CORP (NASDAQ:PODD) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
News headline image
4 Analysts Assess Insulet: What You Need To Know ↗
 
Via Benzinga
News headline image
Insulet to Present at the Jefferies Global Healthcare Conference
From Insulet Corporation
Via Business Wire
News headline image
MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio? ↗
Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price targets & more positive news. 
Via Benzinga
News headline image
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains ↗
Ride the coattails of institutional investors with these three overlooked stocks smart money investors are piling into for triple-digit gains. 
Via InvestorPlace
News headline image
Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market ↗
Latest on Insulet and its legal battle with EOFlow. Understand the impact of the appellate court's decision on market dynamics and Insulet's future. 
Via Benzinga
News headline image
Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday? ↗
Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York. 
Via Benzinga
News headline image
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? ↗
A worse-than-expected University of Michigan’s May consumer report halted stock gains on Friday, sparking worries about a potential decline in consumer health amid perceived rising price pressures. 
Via Benzinga
Topics Economy
News headline image
PODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024 ↗
PODD stock results show that Insulet beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
From Insulet Corporation
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
From Insulet Corporation
Via Business Wire
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.